World
U.S. Raises Ante in Vaccine Race With $1.2 Billion for Astra
- Astra to deliver 300 million doses to the U.S. by October
- U.S. funding for Astra follows previous deal with Sanofi
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
The U.S. threw its weight behind one of the fastest-moving experimental solutions to the coronavirus pandemic, pledging as much as $1.2 billion to AstraZeneca Plc to help make the University of Oxford’s Covid vaccine.